Nir Peled

43.4k citations
309 papers · 18.7k · 6 hit papers · h-index 55

Impact in

Papers in

    • Lung Cancer Treatments and Mutations 98
    • Lung Cancer Diagnosis and Treatment 35
    • Cancer Immunotherapy and Biomarkers 52
    • Lung Cancer Research Studies 28
    • Colorectal Cancer Treatments and Studies 24

Nir Peled

297 papers receiving 18.3k citations

Nir Peled's Hit Papers

Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50% 2021 · 655 citations
6550+4+9Years since publication2.0k4.0k6.0k

Peers

Nir Peled
Comparison fields: 5 of 156
  • Oncology 8.3k
  • Pulmonary and Respiratory Medicine 6.3k
  • Cancer Research 1.5k
  • Immunology 1.8k
  • Endocrine and Autonomic Systems 461
Replace David A. Geller with:
David A. Geller United States
Shaf Keshavjee Canada
Meinrad Gawaz Germany
Hiroyuki Kuwano Japan
William E. Grizzle United States
Yoshihiko Maehara Japan
Markus W. Büchler Germany
Martin R. Bennett United Kingdom
Toshiaki Watanabe Japan
Mat J.A.P. Daemen Netherlands
Nir Peled relative to David A. Geller United States David A. Geller's profile →
Citations per field
00.5×3.7×
David A. Geller · 1×
Citations per year

Countries citing papers authored by Nir Peled

Since Specialization
Citations

This map shows the geographic impact of Nir Peled's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nir Peled with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nir Peled more than expected).

Fields of papers citing papers by Nir Peled

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nir Peled. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nir Peled. The network helps show where Nir Peled may publish in the future.

Co-authors

The 25 scholars most cited alongside Nir Peled, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nir Peled Line = papers co-authored together Nir Peled links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 309 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
Hit paper breakdown →
20167276
2
Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater
Hit paper breakdown →
20191154
3
Volatile Organic Compounds of Lung Cancer and Possible Biochemical Pathways
Hit paper breakdown →
2012793
4
Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50%
Hit paper breakdown →
2021655
5
Biomarkers in Lung Cancer Screening: Achievements, Promises, and Challenges
Hit paper breakdown →
2018373
6
Characterization of 298 Patients with Lung Cancer Harboring MET Exon 14 Skipping Alterations
Hit paper breakdown →
2016281
7 2017262
8 2016197
9 2012169
10 1999167
11 2018166
12 2009161
13 2011161
14 2018160
15 2020142
16 2006122
17 2001120
18 2015119
19 2016113
20 2015111

About Nir Peled

Nir Peled is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Cancer Research and Surgery, having authored 309 papers that have together received 18.7k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (98 papers), Cancer Immunotherapy and Biomarkers (52 papers), Lung Cancer Diagnosis and Treatment (35 papers), Lung Cancer Research Studies (28 papers), Cancer Genomics and Diagnostics (25 papers), Colorectal Cancer Treatments and Studies (24 papers), Advanced Chemical Sensor Technologies (23 papers) and Obstructive Sleep Apnea Research (10 papers). The work is most often cited by research in Oncology (8.3k citations), Pulmonary and Respiratory Medicine (6.3k citations), Cancer Research (1.5k citations), Immunology (1.8k citations) and Endocrine and Autonomic Systems (461 citations). Nir Peled has collaborated with scholars based in Israel, United States and Spain. Frequent co-authors include Rina Hui, Delvys Rodríguez‐Abreu, Maya Gottfried, Andrew Robinson, Katsuyuki Hotta, Tibor Csőszi, Sinéad Cuffe, Suman Rao, Ali Tafreshi and Julie R. Brahmer. Their work appears in journals such as Journal of Thoracic Oncology, Journal of Clinical Oncology, Annals of Oncology, European Journal of Clinical Microbiology & Infectious Diseases and Lung Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact